Stay updated on Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Sign up to get notified when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now displays Revision: v3.5.4, replacing the previous Revision: v3.5.3. This indicates a new version of the page/document has been released.
    Difference
    0.1%
    Check dated 2026-05-15T16:30:26.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer “Revision” number was updated from v3.5.2 to v3.5.3, indicating a site/backend version change rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:21:13.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:07.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added the disease category Squamous cell carcinoma of the head and neck and introduced a Resources section linking the Genetic and Rare Diseases Information Center.
    Difference
    0.2%
    Check dated 2026-04-02T15:11:21.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and v3.4.3 was removed. The update does not modify study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-19T04:59:00.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3; no visible content changes on the page.
    Difference
    0.1%
    Check dated 2026-03-12T00:26:02.000Z thumbnail image

Stay in the know with updates to Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reirradiation With Pembrolizumab in Head-and-Neck Clinical Trial page.